Literature DB >> 16935137

Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial.

Andreas Koster1, Semi Buz, Roland Hetzer, Hermann Kuppe, Klaus Breddin, Sebastian Harder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16935137     DOI： 10.1016/j.jtcvs.2006.04.034

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  9 in total

1.  Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia.

Authors:  Julia Hillebrand; Juergen Sindermann; Christoph Schmidt; Rolf Mesters; Sven Martens; Mirela Scherer
Journal:  J Artif Organs       Date:  2015-06-05       Impact factor: 1.731

2.  Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period.

Authors:  Joo Heung Yoon; Robert W Yeh; Kyung Hun Nam; William D Hoffman; Arvind K Agnihotri; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

3.  Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.

Authors:  Duane Bates; Sarah Griffin; Barb Angel
Journal:  Can J Hosp Pharm       Date:  2009-07

4.  Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.

Authors:  John R Bartholomew; Carolynn E Pietrangeli; Marcie J Hursting
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 5.  Argatroban in the management of heparin-induced thrombocytopenia.

Authors:  Luciano Babuin; Vittorio Pengo
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

6.  Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.

Authors:  David P Webb; Matthew T Warhoover; Susan S Eagle; James P Greelish; David X Zhao; John G Byrne
Journal:  J Extra Corpor Technol       Date:  2008-06

Review 7.  Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Authors:  Marcie J Hursting; Joseph Soffer
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  An Anti-Coagulation Conundrum: Implantation of Total Artificial Heart in a Patient with Heparin-Induced Thrombocytopenia Type II.

Authors:  Theodore J Cios; Yuliana Salamanca-Padilla; Dmitri Guvakov
Journal:  Am J Case Rep       Date:  2017-03-23

9.  The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.

Authors:  Andreas Koster; Karl-Georg Fischer; Sebastian Harder; Fritz Mertzlufft
Journal:  Biologics       Date:  2007-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.